Stock Code: 300957 Stock Name: Botanee Announcement No.: 2024-012
Yunnan Botanee Bio-Technology Group Co., Ltd.
Quarterly Report 2024 Q1
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate andcomplete without false record, misleading statement or major omission.Notices:
1. The Board of Directors and Board of Supervisors, as well as directors, supervisors and senior management of the Companyguarantee that the present quarterly report is true, accurate and complete without false record, misleading statement or majoromission, and undertake the joint and several legal liabilities.
2. Botanee’s legal representative Mr. Guo Zhenyu, CFO Mr. Wang Long, and Head of Accounting Department Mr. Liu Zhaofenghereby declare that the financial statements herein are true, accurate, and complete.
3. Whether Q1 report has been audited
□Yes ?No
I. Key Financial Data
(i) Major Accounting Data and Financial IndicatorsWhether the Company needs to retrospectively adjust or restate the accounting data for the previous years
□Yes ?No
This Reporting Period | Same Period of the Previous Year | Change in This Reporting Year over the Same Period of the Previous Year (%) | |
Operating revenue (CNY) | 1,096,940,645.49 | 863,307,083.80 | 27.06% |
Net profit attributable to shareholders of the listed company (CNY) | 176,845,231.47 | 158,265,044.32 | 11.74% |
Net profit attributable to shareholders of the listed company after deducting non-recurring profit or loss (CNY) | 154,346,690.47 | 126,577,596.71 | 21.94% |
Net cash flows from operating activities (CNY) | -157,714,269.99 | -196,770,597.63 | 19.85% |
Basic earnings per share (CNY/share) | 0.42 | 0.37 | 13.51% |
Diluted earnings per share (CNY/share) | 0.42 | 0.37 | 13.51% |
Weighted average return on net assets | 3.07% | 2.81% | Increase 0.26pcts |
End of This Reporting Period | End of the Previous Year | Change in the End of This Reporting Year over the End of the Previous Year (%) | |
Total assets | 7,060,400,018.28 | 7,506,930,342.79 | -5.95% |
Net assets attributable to shareholders of the listed company (CNY) | 5,958,766,569.72 | 5,860,994,371.02 | 1.67% |
Whether the Company’s share capital has changed and affected the amount of shareholders’ equity due to new issues, additionalissues, rights issues, stock ownership incentive exercise, buybacks and other reasons from the end of the reporting period to thedisclosure date of the quarterly report?Yes ?No
This Reporting Period | |
Dividends for Preferred Shares That Have Been Paid (CNY) | |
Interest Paid on Perpetual Bonds (CNY) | |
Fully Diluted Dividends per Share Based on Latest Share Capital (CNY/Share) | 0.4175 |
(ii) Item and Amount of Non-recurring Profit and Loss
? Applicable □ N/A
Unit: CNY
Item | Amount for | Description |
This Reporting Period | ||
Profit or loss from disposal of non-current assets (including the offset part of provisions for impairment of assets) | 3,159,516.70 | Profit or loss from disposal of non-current assets |
Government subsidies included in the current profit or loss (excluding those closely related to the normal business of the Company, granted under the national policies and continuously enjoyed according to certain standards with lasting impacts on the Company’s profit and loss) | 6,081,973.96 | Government subsidies and incentives included in “other income” item |
Except for the effective hedging activities related to the Company’s ordinary activities, profit or loss arising from changes in fair value of financial assets and financial liabilities held by non-financial enterprises, and profit or loss arising from from disposal of financial assets and financial liabilities | 12,444,776.07 | Profit or loss from changes in fair value of cash management projects handled by third parties with the Company’s authorization |
Profits and losses on the assets by entrusting others to invest or manage | 10,720,698.39 | Income from mature investment in cash management projects handled by third parties with the Company’s authorization |
Other non-operating income and expenses other than the above | -5,751,517.93 | Mainly the donations for public welfare |
Less: Effect on income tax | 4,012,913.49 | |
Effect on minority interests (after-tax) | 143,992.70 | |
Total | 22,498,541.00 | -- |
Other profit or loss conforming to the definition of non-recurring profit or loss
□ Applicable ? N/A
There is no other profit or loss conforming to the definition of non-recurring profit or loss
Explanation on defining the non-recurring profits and losses set out in the Explanatory Announcement No. 1 on InformationDisclosure for Companies Offering Securities to the Public - Non-Recurring Profit or Loss as recurring profits and losses
□ Applicable ? N/A
There is no non-recurring profits and losses set out in the Explanatory Announcement No. 1 on Information Disclosure forCompanies Offering Securities to the Public - Non-Recurring Profit or Loss as recurring profits and losses(iii) Changes in Major Accounting Data and Financial Indicators and Reasons
? Applicable □ N/A
1. Changes in the Items of Consolidated Balance Sheet at the End of the Reporting Period and Reasons
Unit: CNY
Item | Balance at the End of the Reporting Period | Balance at the Beginning of the Year | Change | Proportion on Increase/ Decrease |
Cash at bank and on hand | 1,343,444,241.12 | 2,091,459,861.58 | -748,015,620.46 | -35.77% |
Financial assets held for trading | 1,610,799,112.41 | 1,238,356,707.34 | 372,442,405.07 | 30.08% |
Notes receivable | 24,502,124.46 | -24,502,124.46 | -100.00% | |
Accounts receivable financing | 137,531,755.44 | 156,659,263.78 | -19,127,508.34 | -12.21% |
Prepayments | 142,355,751.12 | 69,279,116.38 | 73,076,634.74 | 105.48% |
Other receivables | 32,793,188.57 | 29,748,433.09 | 3,044,755.48 | 10.24% |
Other current assets | 394,885,442.12 | 446,396,252.76 | -51,510,810.64 | -11.54% |
Projects under construction | 17,926,811.70 | 40,220,147.41 | -22,293,335.71 | -55.43% |
Right-of-use assets | 138,735,183.22 | 100,712,614.93 | 38,022,568.29 | 37.75% |
Deferred income tax assets | 105,499,904.49 | 93,131,250.45 | 12,368,654.04 | 13.28% |
Short-term loans | 169,222,593.55 | 103,816,588.60 | 65,406,004.95 | 63.00% |
Notes payable | 29,733,807.46 | 67,562,710.23 | -37,828,902.77 | -55.99% |
Accounts receivable | 112,449,307.13 | 334,370,604.40 | -221,921,297.27 | -66.37% |
Employee salary payable | 68,560,161.83 | 106,452,763.55 | -37,892,601.72 | -35.60% |
Tax payable | 72,434,971.41 | 132,117,765.46 | -59,682,794.05 | -45.17% |
Other payables | 176,049,497.02 | 449,282,195.16 | -273,232,698.14 | -60.82% |
Other current liabilities | 8,595,035.17 | 5,455,465.77 | 3,139,569.40 | 57.55% |
Long-term loans | 857,142.85 | 4,700,000.00 | -3,842,857.15 | -81.76% |
Lease liabilities and non-current liabilities due within one year | 137,147,012.77 | 105,385,826.61 | 31,761,186.16 | 30.14% |
Treasury shares | 200,212,194.96 | 109,838,205.82 | 90,373,989.14 | 82.28% |
Reasons for Changes:
(1) The balance of monetary resources at the end of the reporting period stood at CNY1,343,444,200, a decrease of CNY748,015,600or about 35.77% compared with the beginning of the year. For changes in major cash flow of the Company’s monetary resourcesduring the reporting period, please refer to 3. Changes in Consolidated Statements of Cash Flow from the Beginning of the Year tothe End of the Reporting Period and Reasons of this Report.
(2) The total balance of trading financial assets at the end of the reporting period stood at CNY1,610,799,100, an increase ofCNY372,442,400 or about 30.08% compared with the beginning of the year, mainly due to the increased immature investmentbalance of cash management projects (managed by third parties with the Company’s authorization and measured at fair value) withavailable funds raised and its own funds within the quota authorized by the general meeting of shareholders at the end of thereporting period.
(3) There was no balance of notes receivable at the end of the reporting period, a significant decrease compared with the beginning ofthe year, mainly due to the mature commercial acceptance held by the Company during the reporting period and the full recovery ofrelevant receivables.
(4) The balance of receivables financing at the end of the reporting period stood at CNY137,531,800, a decrease of CNY19,127,500or about 12.21% compared with the beginning of the year, mainly due to the Company’s bill planning through various means such asacceptance at maturity, advance discount or endorsement transfer according to dynamic capital demands, and the decreased balanceof available bank acceptance at the end of the reporting period.
(5) The balance of prepayments at the end of the reporting period stood at CNY142,355,800, an increase of CNY73,076,600
compared with the beginning of the year or about 105.48%. The prepayments were mainly top-ups for promoting online stores onlarge B2C e-commerce platforms for marketing plans such as live streaming and advertising and production plans on the supplychain in the second quarter of 2024, marketing fees charged by marketing service providers and some core raw materials andmaterials purchased by OEM service providers. At the end of the reporting period, the Company had a big balance of prepayments,which was consistent with the Company’s production, marketing and sales models and cycles. The Company’s major expenses,major suppliers and the proportion of prepayments to total assets at the end of the first quarter of 2024 did not change significantlycompared with the end of the same period of the previous year. At the end of the reporting period, there were no associated parties ofthe Company among those who the Company had to make prepayments to. There was no fund misappropriation or illegal provisionof financial assistance by an associated party. At the end of the reporting period, the Company’s prepayment ratio within one yearwas about 99.01%. These prepayments are expected to be written off within the next 12 months.
(6) The balance of other receivables at the end of the reporting period stood at CNY32,793,200, an increase of CNY3,044,800 orabout 10.24% compared with the beginning of the year, mainly due to the increased rental deposit for logistics stores paid by theCompany during the reporting period.
(7) The balance of other liquid assets at the end of the reporting period stood at CNY394,885,400, a decrease of CNY51,510,800 orabout 11.54% compared with the beginning of the year, mainly due to the decrease in the Company’s outstanding VAT credits andVAT reductions to be verified and deducted at the end of the reporting period.
(8) The balance of projects under construction at the end of the reporting period stood at CNY17,926,800, a decrease ofCNY22,293,300 or about 55.43% compared with the beginning of the year, mainly due to the transfer of the freeze-dried maskproduction line project of the new base of the Company’s central factory to fixed assets after passing the check for acceptance duringthe reporting period. This project only uses the Company’s own funds and will increase the Company’s self-production capacity ofpatch masks after being put into production.
(9) The balance of the right-of-use assets at the end of the reporting period stood at CNY138,735,200, an increase of CNY38,022,600or about 37.75% compared with the beginning of the year, mainly due to the increase in the Company’s current lease contracts forbusiness premises during the reporting period. These business premises rented by the Company were mainly for production, R&D,storage and office purposes at the end of the reporting period.
(10) The balance of deferred income tax assets at the end of the reporting period stood at CNY105,499,900, an increase ofCNY12,368,700 or about 13.28% compared with the beginning of the year, mainly due to the increased deductible temporarydifferences in the Company’s lease liabilities, equity incentive expenses and deductible losses at the end of the reporting period.
(11) The balance of short-term loans at the end of the reporting period stood at CNY169,222,600, an increase of CNY65,406,000 orabout 63.00% compared with the beginning of the year, mainly due to a big increase in short-term financial loans for liquid capitalissued by commercial banks during the reporting period.
(12) The balance of notes payable at the end of the reporting period stood at CNY29,733,800, a decrease of CNY37,828,900 or about
55.99% compared with the beginning of the year, mainly due to the decrease in the remaining immature bank acceptance payable atthe end of the reporting period. At the end of the reporting period, the Company had no notes payable due or unaccepted.
(13) The balance of accounts payable at the end of the reporting period stood at CNY112,449,300, a decrease of CNY221,921,300 orabout 66.37% compared with the beginning of the year, mainly due to the Company’s payments for production materials and
productive services as scheduled. During the reporting period, the Company had no overdue payments due to suppliers.
(14) The balance of salary payable to employees at the end of the reporting period stood at CNY68,560,200, a decrease ofCNY37,892,600 or about 35.60% compared with the beginning of the year, mainly due to the Company’s payment for the year-endone-time bonus to employees for the year 2023 during the reporting period.
(15) The balance of taxes payable at the end of the reporting period stood at CNY72,435,000, a decrease of CNY59,682,800 or about
45.17% compared with the beginning of the year, mainly due to the Company’s payment for various taxes payable preliminarilycalculated by the Company at the beginning of the reporting period.
(16) The balance of other payables at the end of the reporting period stood at CNY176,049,500, a decrease of CNY273,232,700 orabout 60.82% compared with the beginning of the year, mainly due to the Company’s payment for the marketing fees charged bylarge B2C e-commerce platforms and other marketing service providers accrued in the fourth quarter of 2023, and for engineeringequipment for the new base of the central factory and other engineering projects as scheduled, and shorter cycles of other balancespayable. At the end of the reporting period, the Company’s other balances payable were small, consistent with the Company’smarketing and sales models and cycles. The Company’s major expenses, major suppliers and the proportion of other payables to totalassets at the end of the first quarter of 2024 did not change significantly compared with the end of the same period of the previousyear. At the end of the reporting period, there were no associated parties of the Company among those who the Company had tomake prepayments to. There was no fund misappropriation or illegal provision of financial assistance by an associated party.
(17) The balance of other liquid liabilities at the end of the reporting period stood at CNY8,595,000, an increase of CNY3,139,600 orabout 57.55% compared with the beginning of the year, mainly due to the increased balance of returns payable accrued by theCompany at the end of the reporting period.
(18) The balance of long-term loans at the end of the reporting period stood at CNY857,100, a decrease of CNY3,842,900 comparedwith the beginning of the year. This big decrease was mainly due to the Company’s repayment of the principal of long-term financialloans from commercial banks at the end of the reporting period according to dynamic capital demands.
(19) The total balance of lease liabilities and non-liquid liabilities due within one year at the end of the reporting period stood atCNY137,147,000, an increase of CNY31,761,200 or about 30.14% compared with the beginning of the year, mainly due to theincrease in the Company’s current lease contracts for business premises at the end of the reporting period. These business premisesrented by the Company were mainly for production, R&D, storage and office purposes at the end of the reporting period. The totalbalance of lease liabilities and non-liquid liabilities due within one year at the end of the reporting period was basically consistentwith the changes in the balance of right-of-use assets at the end of the reporting period.
(20) The balance of treasury shares at the end of the reporting period stood at CNY200,212,200, an increase of CNY90,374,000 orabout 82.28% compared with the beginning of the year, mainly due to the increase in the Company’s ordinary shares repurchasedwith its own funds through call auction in accordance with the resolution of the Board of Directors during the reporting period. Fordetails, please refer to the Announcement by Yunnan Botanee Bio-Technology Group Co., Ltd. on the Progress of Share Repurchase(2024-009) disclosed on cninfo’s website (http://www.cninfo.com.cn).。
2. Changes in the Items of Consolidated Income Statement from the Beginning of the Year to the End ofthe Reporting Period and Reasons
Unit: CNY
Item | Current Amount | Amount Incurred in the Same Period of the Previous Year | Change | Proportion on Increase/ Decrease |
Operating revenue | 1,096,940,645.49 | 863,307,083.80 | 233,633,561.69 | 27.06% |
Operating costs | 306,201,911.22 | 206,280,038.13 | 99,921,873.09 | 48.44% |
Tax and additional tax | 8,603,141.17 | 7,790,149.34 | 812,991.83 | 10.44% |
Marketing expenses | 512,649,843.99 | 410,938,284.12 | 101,711,559.87 | 24.75% |
Administration expenses | 75,651,161.21 | 66,631,543.70 | 9,019,617.51 | 13.54% |
Other incomes | 7,985,377.36 | 4,825,935.94 | 3,159,441.42 | 65.47% |
Investment income | 10,575,655.89 | 5,688,720.31 | 4,886,935.58 | 85.91% |
Income from changes in fair value | 12,444,776.07 | 31,451,953.37 | -19,007,177.30 | -60.43% |
Losses from credit impairment (losses are marked with “-”) | -752,582.03 | -2,738,672.93 | 1,986,090.90 | 72.52% |
Losses from asset impairment(losses are marked with “-”) | 1,521,923.22 | -4,313,168.81 | 5,835,092.03 | 135.29% |
Asset disposal income | 3,159,516.70 | 718,876.65 | 2,440,640.05 | 339.51% |
Income tax | 22,507,593.29 | 18,954,031.76 | 3,553,561.53 | 18.75% |
Reasons for Changes:
(1) The Company’s operating revenue from the beginning of the year to the end of the reporting period stood at CNY1,096,940,600,an increase of CNY233,633,600 or about 27.06% compared with the same period of the previous year, mainly due to the furtherimprovement of the Company’s products and brand awareness from the beginning of the year to the end of the reporting period,which led to bigger sales scale and higher sales revenue. These figures included the sales revenue of Za and PURE&MILD, whichthe Company successfully acquired on October 31, 2023. Taking into consideration only the brands included during the last reportingperiod, the Company’s operating revenue stood at about CNY959,395,100 from the beginning of the year to the end of the reportingperiod, an increase of about 11.13%.
(2) The Company’s operating costs from the beginning of the year to the end of the reporting period stood at CNY306,201,900, anincrease of CNY99,921,900 or about 48.44% compared with the same period of the previous year, mainly due to the increasedoperating costs as the Company’s sales scale and sales revenue rose. These figures included the marketing costs of Za andPURE&MILD, which the Company successfully acquired on October 31, 2023. Taking into consideration only the brands includedduring the last reporting period, the Company’s operating costs stood at about CNY247,494,900 from the beginning of the year to theend of the reporting period, an increase of about 19.98%. The gross profit margin on sales was about 74.20%. The growth of theCompany’s operating costs basically matched the growth of the sales scale, and the production costs were basically stable. From thebeginning of the year to the end of the reporting period, the growth rate of operating costs was slightly higher than that of operatingrevenue, mainly due to the dynamic adjustments of the Company’s promotion policies and product portfolios according to the market.
(3) The Company’s tax and additional tax from the beginning of the year to the end of the reporting period stood at CNY8,603,100,an increase of CNY813,000 or about 10.44% compared with the same period of the previous year, mainly due to the increased taxand additional tax as the Company’s sales scale and sales revenue rose. The growth rate of the Company’s tax and additional taxfrom the beginning of the year to the end of the reporting period was lower than that of the sales revenue, mainly due to the decreased
input VAT plus tax credits and the decreased taxable sales revenue for consumption tax during the reporting period.
(4) The Company’s marketing expenses from the beginning of the year to the end of the reporting period stood at CNY512,649,800,an increase of CNY101,711,600 or about 24.75% compared with the same period of the previous year, mainly due to thecontinuously increased investment in brand image promotion and communication, human resources and storage as the Company’ssales scale and sales revenue rose. The growth of the Company’s marketing expenses basically matched that of the sales scale.
(5) The Company’s administration expenses from the beginning of the year to the end of the reporting period stood atCNY75,651,200, an increase of CNY9,019,600 or about 13.54% compared with the same period of the previous year, mainly due tothe increased salary of managerial staff, equity incentive costs and other administrative expenses as the Company scaled up. Thegrowth rate of the Company’s administration expenses from the beginning of the year to the end of the reporting period was lowerthan that of the sales scale, mainly due to the effective cost reduction and efficiency improvement measures for administrativefunctions and back-stage management expenses implemented by the Company during the reporting period.
(6) The Company’s other incomes from the beginning of the year to the end of the reporting period stood at CNY7,985,400, anincrease of CNY3,159,400 or about 65.47% compared with the same period of the previous year, mainly due to the increased taxcredits of input VAT and the increased revenue-related government subsidies for the Company compared with the same period ofthe previous year from the beginning of the year to the end of the reporting period.
(7) The Company’s investment income from the beginning of the year to the end of the reporting period stood at CNY10,575,700,an increase of CNY4,886,900 or about 85.91% compared with the same period of the previous year. This big increase was mainlydue to the increased maturity yield generated by the Company’s cash management projects (managed by third parties with theCompany’s authorization and measured at fair value) from the beginning of the year to the end of the reporting period.
(8) The Company’s net income from changes in fair value from the beginning of the year to the end of the reporting period stoodat CNY12,444,800, a decrease of CNY19,007,200 or about 60.43% compared with the same period of the previous year, mainlydue to the decreased fair value fluctuations of the cash management projects (managed by third parties with the Company’sauthorization and measured at fair value) compared with the same period of the previous year during the reporting period.
(9) The Company’s net losses from credit impairment from the beginning of the year to the end of the reporting period stood atCNY752,600, a decrease of CNY1,986,100 compared with the same period of the previous year. This big decrease was mainly dueto the decreased provision for receivables impairment during the reporting period. During the reporting period, there were nochanges in the Company’s accounting policies and accounting estimates for the provision for receivables impairment.
(10) The Company’s net income from asset impairment from the beginning of the year to the end of the reporting period stood atCNY1,521,900, mainly due to the net write-back of the Company’s provision for inventory impairment. During the reportingperiod, there were no changes in the Company’s accounting policies and accounting estimates for the provision for inventoryimpairment.
(11) The Company’s asset disposal income from the beginning of the year to the end of the reporting period stood atCNY3,159,500, an increase of CNY2,440,600 compared with the same period of the previous year. This big year-on-year increasewas mainly due to the early termination of lease contracts and the cancellation of right-of-use assets during the reporting period.
(12) The Company’s income tax from the beginning of the year to the end of the reporting period stood at CNY22,507,600, anincrease of CNY3,553,600 or about 18.75% compared with the same period of the previous year, mainly due to the increasedcorporate income tax as the sales scale and total profits increased.
3. Changes in the Items of Consolidated Statement of Cash Flow from the Beginning of the Year to theEnd of the Reporting Period and Reasons
Unit: CNY
Item | Current Amount | Amount Incurred in the Same Period of the Previous Year | Change | Proportion on Increase/ Decrease |
Cash inflow frombusiness operations
Cash inflow from business operations | 1,289,100,731.71 | 956,511,167.50 | 332,589,564.21 | 34.77% |
Cash outflow to business operations | 1,446,815,001.70 | 1,153,281,765.13 | 293,533,236.57 | 25.45% |
Cash inflow from investment activities | 681,304,135.99 | 1,062,386,090.04 | -381,081,954.05 | -35.87% |
Cash outflow toinvestment activities
Cash outflow to investment activities | 1,112,435,766.79 | 1,679,824,366.87 | -567,388,600.08 | -33.78% |
Cash inflow from financing activities | 69,222,593.55 | 69,222,593.55 | ||
Cash outflow to financing activities | 225,881,999.09 | 21,609,005.20 | 204,272,993.89 | 945.31% |
Reasons for Changes:
(1) The Company’s cash inflow from business operations from the beginning of the year to the end of the reporting period stood atCNY1,289,100,700, an increase of CNY332,589,600 or about 34.77% compared with the same period of the previous year, mainlydue to the increased cash inflow brought by the rapid growth of the Company’s sales scale and sales revenue. From the beginningof the year to the end of the reporting period, the growth of cash inflow from business operations basically matched that of thesales scale.
(2) The Company’s cash outflow to business operations from the beginning of the year to the end of the reporting period stood atCNY1,446,815,000, an increase of CNY293,533,200 or about 25.45% compared with the same period of the previous year, mainlydue to the increase in other operating expenses incurred by brand image promotion and communication, human resources and e-commerce platforms. From the beginning of the year to the end of the reporting period, the growth of cash outflow to businessoperations basically matched that of the sales scale.
(3) The Company’s cash inflow from investment activities from the beginning of the year to the end of the reporting period stoodat CNY681,304,100, a decrease of CNY381,082,000 or about 35.87% compared with the same period of the previous year, mainlydue to the immaturity of major cash management projects managed by third parties with the Company’s authorization at the end ofthe reporting period.
(4) The Company’s cash outflow to investment activities from the beginning of the year to the end of the reporting period stood atCNY1,112,435,800, a decrease of CNY567,388,600 or about 33.78% compared with the same period of the previous year, mainlydue to the immaturity of major cash management projects managed by third parties with the Company’s authorization and
decreased investment in cash management projects with available funds raised and its own funds within the smaller quotaauthorized by the general meeting of shareholders from the beginning of the year to the end of the reporting period.
(5) The Company’s cash inflow from financing activities from the beginning of the year to the end of the reporting period stood atCNY69,222,600, mainly due to the cash of short-term financial loans received from commercial banks for liquid capital during thereporting period.
(6) The Company’s cash outflow to financing activities from the beginning of the year to the end of the reporting period stood atCNY225,882,000, an increase of CNY204,273,000 compared with the same period of the previous year, mainly because theCompany repurchased its ordinary shares with its own funds through call auction according to the resolution of the Board ofDirectors and repaid the principal and interest of long-term and short-term financial loans to commercial banks according todynamic capital demands.
II. Shareholder Information(i) Total Number of Ordinary Shareholders and the Number of Preferred Shareholders Whose VotingRights Have Been Restored and Shareholding of Top 10 Shareholders
Unit: Share
Total number of ordinary share shareholder s as of the end of the reporting period | 34,356 | Total number of preferred shareholders (if any) resuming voting rights at the end of the reporting period | ||||
Shareholdings of top 10 shareholders (excluding shares lent through conversions) | ||||||
Shareholder Name | Nature | Shareholding proportion(%) | Number of shares held | Number of shares subject to trading restriction held | Pledged, marked or frozen shares | |
Status of shares | Quantity | |||||
Kunming Nuona Technology Co., Ltd. | Domestic non-state-owned corporate | 46.08% | 195,212,611.00 | Not Applicable | ||
Tianjin Sequoia Juye Equity Investment Partnership (Limited Partnership) | Domestic non-state-owned corporate | 14.58% | 61,763,257.00 | Not Applicable | ||
Xiamen Zhenli Consulting Co., Ltd. | Domestic non-state-owned corporate | 6.54% | 27,685,934.00 | Not Applicable | ||
Hong Kong Securities Clearing Company Limited | Overseas legal person | 3.28% | 13,886,556.00 | Not Applicable | ||
Yunnan Haqisheng Enterprise Management Co., Ltd. | Domestic non-state-owned corporate | 2.60% | 10,993,678.00 | Not Applicable | ||
Xiamen Chonglou Yunshui Investment Partnership (Limited Partnership) | Domestic non-state-owned corporate | 1.30% | 5,526,929.00 | Not Applicable |
Kuwait Investment Authority | Overseas legal person | 1.25% | 5,285,437.00 | Not Applicable | |||
National Social Security Fund 102 Portfolio | Miscellaneous | 0.66% | 2,816,813.00 | Not Applicable | |||
Industrial and Commercial Bank of China Limited - Efund GEM Exchange-traded Open Index Securities Investment Fund | Miscellaneous | 0.57% | 2,433,281.00 | Not Applicable | |||
National Social Security Fund 504 Portfolio | Miscellaneous | 0.47% | 1,992,075.00 | Not Applicable | |||
Shareholdings of top ten shareholders without trading limited condition | |||||||
Shareholder | Number of shares not subject to trading restriction as at the end of reporting period | Types of shares | |||||
Types of shares | Quantity | ||||||
Kunming Nuona Technology Co., Ltd. | 195,212,611.00 | CNY common shares | 195,212,611.00 | ||||
Tianjin Sequoia Juye Equity Investment Partnership (Limited Partnership) | 61,763,257.00 | CNY common shares | 61,763,257.00 | ||||
Xiamen Zhenli Consulting Co., Ltd. | 27,685,934.00 | CNY common shares | 27,685,934.00 | ||||
Hong Kong Securities Clearing Company Limited | 13,886,556.00 | CNY common shares | 13,886,556.00 | ||||
Yunnan Haqisheng Enterprise Management Co., Ltd. | 10,993,678.00 | CNY common shares | 10,993,678.00 | ||||
Xiamen Chonglou Yunshui Investment Partnership (Limited Partnership) | 5,526,929.00 | CNY common shares | 5,526,929.00 | ||||
Kuwait Investment Authority | 5,285,437.00 | CNY common shares | 5,285,437.00 | ||||
National Social Security Fund 102 Portfolio | 2,816,813.00 | CNY common shares | 2,816,813.00 | ||||
Industrial and Commercial Bank of China Limited - Efund GEM Exchange-traded Open Index Securities Investment Fund | 2,433,281.00 | CNY common shares | 2,433,281.00 | ||||
National Social Security Fund 504 Portfolio | 1,992,075.00 | CNY common shares | 1,992,075.00 | ||||
Description on the related relationship or concerted action among the above shareholders | Kunming Nuona Technology Co., Ltd. and Yunnan Haqisheng Enterprise Management Co., Ltd. are both controlled by Guo Zhenyu and KEVIN GUO (father and son), the actual controllers of the Company. Except this, the Company does not know whether other shareholders have an association or a concerted action relationship. | ||||||
Description of top 10 shareholders participating in securities margin trading (if any) | Not applicable. |
Note: As of March 31, 2024, the number of shares held under the unlimited sale condition in the buyback special securitiesaccount of Yunnan Botanee Bio-Technology Group Co., Ltd. was 2,994,618 shares, accounting for approximately 0.71% of theCompany’s issued CNY ordinary shares at the end of the reporting period.
Securities financing and share lending of shareholders holding more than 5%, top 10 shareholders and top 10 shareholders ofunlimited tradable shares
□Applicable ?Not Applicable
Changes over the previous period because top 10 shareholders and the top 10 shareholders holding shares not subject to tradingrestriction lend/return securities financing
□Applicable ?Not Applicable
(ii) Total number of preferred shareholders and top 10 preferred shareholders of the Company
□Applicable ?Not Applicable
(III) Changes in Restricted Shares?Applicable ?Not Applicable
Unit: Share
Shareholder Name | Number of restricted shares as at the beginning of the period | Termination in the current period Number of restricted shares | Increase in the current period Number of restricted shares | Number of Restricted shares as at the end of the period | Reasons for trading restriction | Release date of restriction |
Kunming Nuona Technology Co., Ltd. | 195,212,611.00 | 195,212,611.00 | Shares before initial public offerings | March 25, 2024 | ||
Yunnan Haqisheng Enterprise Management Co., Ltd. | 10,993,678.00 | 10,993,678.00 | Shares before initial public offerings | March 25, 2024 | ||
Total | 206,206,289.00 | 206,206,289.00 |
Note: For details, please refer to the Indicative Announcement on the Circulation of Some Issued Shares of Yunnan Botanee Bio-Technology Group Co., Ltd. (2024-008) before IPO on cninfo’s website (http://www.cninfo.com.cn).
III. Other Important Matters
□Applicable ?Not Applicable
IV. Quarterly Financial Statement(i) Financial Statement
1. Consolidated Balance Sheet
Prepared by: Yunnan Botanee Bio-Technology Group Co., Ltd.
March 31, 2024
Unit: CNY
Item | Balance at the End of the Reporting Period | Balance at the Beginning of the Reporting Period |
Current assets: | ||
Cash at bank and on hand | 1,343,444,241.12 | 2,091,459,861.58 |
Settlement reserves | ||
Loans to banks and other financial institutions | ||
Financial assets held for trading | 1,610,799,112.41 | 1,238,356,707.34 |
Derivative financial assets | ||
Notes receivable | 24,502,124.46 | |
Accounts receivable | 512,174,991.94 | 561,761,929.57 |
Receivables financing | 137,531,755.44 | 156,659,263.78 |
Advances to suppliers | 142,355,751.12 | 69,279,116.38 |
Premiums receivable | ||
Reinsurance premium receivable | ||
Reinsurance contract reserves receivable | ||
Other accounts receivable | 32,793,188.57 | 29,748,433.09 |
Including: interest receivable | ||
Dividends receivable | ||
Financial assets purchased under agreement store sell | ||
Inventories | 830,566,558.90 | 904,413,283.67 |
Including: data resources | ||
Contract assets | ||
Held-for-sale assets | ||
Current portion of non-current assets | ||
Other current assets | 394,885,442.12 | 446,396,252.76 |
Total current assets | 5,004,551,041.62 | 5,522,576,972.63 |
Non-current assets: | ||
Disbursement of loans and advances to customers | ||
Debt investment | ||
Other debt investment | ||
Long-term receivables | ||
Long-term equity investment | 218,370,108.65 | 212,015,151.15 |
Investment in other equity instruments | ||
Other non-current financial assets | 91,449,823.00 | 86,449,823.00 |
Investment real estates | 8,702,323.26 | 9,021,481.56 |
Fixed assets | 686,030,584.71 | 667,204,436.83 |
Projects under construction | 17,926,811.70 | 40,220,147.41 |
Productive biological assets | ||
Oil and gas assets |
Right-of-use assets | 138,735,183.22 | 100,712,614.93 |
Intangible assets | 199,099,505.63 | 193,108,638.64 |
Including: data resources | ||
Development expenditures | ||
Including: data resources | ||
Goodwill | 413,740,760.61 | 413,740,760.61 |
Long-term deferred expenses | 93,306,043.71 | 93,317,644.84 |
Deferred income tax assets | 105,499,904.49 | 93,131,250.45 |
Other non-current assets | 82,987,927.68 | 75,431,420.74 |
Total non-current assets | 2,055,848,976.66 | 1,984,353,370.16 |
Total assets | 7,060,400,018.28 | 7,506,930,342.79 |
Current liabilities: | ||
Short-term borrowings | 169,222,593.55 | 103,816,588.60 |
Borrowings from the central bank | ||
Placements from banks and other financial institutions | ||
Financial liabilities held for trading | ||
Derivative financial liabilities | ||
Notes payable | 29,733,807.46 | 67,562,710.23 |
Accounts payable | 112,449,307.13 | 334,370,604.40 |
Advances from customers | ||
Contract liabilities | 50,698,653.60 | 50,053,638.68 |
Financial assets sold under agreements to repurchase | ||
Customer bank deposits and due to banks and other financial institutions | ||
Customer brokerage deposits | ||
Securities underwriting brokerage deposits | ||
Employee compensation payable | 68,560,161.83 | 106,452,763.55 |
Taxes payable | 72,434,971.41 | 132,117,765.46 |
Other payables | 176,049,497.02 | 449,282,195.16 |
Including: interests payable | 69,661.77 | |
Dividends payable | 4,305.04 | |
Handling charges and commission payable | ||
Reinsurance premium payable | ||
Held-for-sale liabilities | ||
Non-current liabilities due within one year | 55,891,140.02 | 42,102,294.00 |
Other current liabilities | 8,595,035.17 | 5,455,465.77 |
Total current liabilities | 743,635,167.19 | 1,291,214,025.85 |
Non-current liabilities: | ||
Insurance contract reserves | ||
Long-term borrowings | 857,142.85 | 4,700,000.00 |
Bonds payable | ||
Including: Preferred shares | ||
Perpetual bonds | ||
Lease liabilities | 81,255,872.75 | 63,283,532.61 |
Long-term payables | 8,600,000.00 | 8,600,000.00 |
Long-term employee benefits payable | ||
Estimated liabilities | ||
Deferred income | 77,500,127.96 | 82,862,738.40 |
Deferred tax liabilities | 39,370,161.08 | 40,452,457.50 |
Other non-current liabilities | ||
Total non-current liabilities | 207,583,304.64 | 199,898,728.51 |
Total liabilities | 951,218,471.83 | 1,491,112,754.36 |
Owners' equity: | ||
Share capital | 423,600,000.00 | 423,600,000.00 |
Other equity instruments | ||
Including: Preferred shares | ||
Perpetual bonds | ||
Capital reserves | 2,859,970,626.92 | 2,846,004,685.04 |
Less: treasury shares | 200,212,194.96 | 109,838,205.82 |
Other comprehensive incomes | -1,101,763.25 | 47,153.49 |
Special reserves | ||
Surplus reserve | 211,081,299.10 | 211,081,299.10 |
General risk provision | ||
Undistributed profit | 2,665,428,601.91 | 2,490,099,439.21 |
Total owners' equity attributable to the parent company | 5,958,766,569.72 | 5,860,994,371.02 |
Minority interest | 150,414,976.73 | 154,823,217.41 |
Total owners' equity | 6,109,181,546.45 | 6,015,817,588.43 |
Total liabilities and owners' equity | 7,060,400,018.28 | 7,506,930,342.79 |
Legal representative: Guo Zhenyu
CFO: Wang Long
Head of Accounting Department: LiuZhaofeng
2. Consolidated Income Statement
Unit: CNY
Item | Amount of the Reporting Period | Amount of Precious Reporting Period |
I. Total operating revenue | 1,096,940,645.49 | 863,307,083.80 |
Including: Operating revenue | 1,096,940,645.49 | 863,307,083.80 |
Interest income | ||
Earned premiums | ||
Handling charges and commission income | ||
II. Total operating cost | 931,179,210.70 | 718,760,135.76 |
Including: operating costs | 306,201,911.22 | 206,280,038.13 |
Interest expenses | ||
Handling charges and commission expenses | ||
Surrender value | ||
Net payments for insurance claims | ||
Net provision for insurance contract reserves | ||
Policy dividend expenses | ||
Reinsurance expenses | ||
Taxes and surcharges | 8,603,141.17 | 7,790,149.34 |
Selling expenses | 512,649,843.99 | 410,938,284.12 |
Management expenses | 75,651,161.21 | 66,631,543.70 |
R&D expenses | 32,646,832.96 | 33,955,217.71 |
Financial expenses | -4,573,679.85 | -6,835,097.24 |
Including: interest expenses | 2,770,460.67 | 1,098,960.38 |
Interest income | -7,594,888.61 | -8,274,640.69 |
Add: other incomes | 7,985,377.36 | 4,825,935.94 |
Investment income (loss to be listed with “-”) | 10,575,655.89 | 5,688,720.31 |
Including: income from investment in associates and joint ventures | -145,042.50 | |
Revenue from derecognition of financial assets at amortized cost | 5,058,786.22 | |
Exchange earnings (losses to be listed with “-”) | ||
Net exposure hedging income (loss to be listed with “-”) | ||
Profit arising from changes in fair value (loss expressed with "- ") | 12,444,776.07 | 31,451,953.37 |
Credit impairment losses (losses to be listed with “-”) | -752,582.03 | -2,738,672.93 |
Asset impairment loss (loss to be listed with "-") | 1,521,923.22 | -4,313,168.81 |
Incomes of assets disposal (losses to be listed with “-”) | 3,159,516.70 | 718,876.65 |
III. Operating profit (loss to be listed with "-") | 200,696,102.00 | 180,180,592.57 |
Add: non-operating revenue | 268,588.39 | 400,768.55 |
Less: Non-operating expenses | 6,020,106.32 | 6,612,043.18 |
IV. Total profit (total loss to be listed with "-") | 194,944,584.07 | 173,969,317.94 |
Less: income tax expenses | 22,507,593.29 | 18,954,031.76 |
V. Net profit (net loss to be listed with "-") | 172,436,990.78 | 155,015,286.18 |
(I) Classified by going concern | ||
1. Net profit from continuing operations (net loss to be listed with “-”) | 172,436,990.78 | 155,015,286.18 |
2. Net profit from discontinued operations (net loss to be listed with "-") | ||
(II) Classified by attribution of ownership | ||
1.Net profit attributable to the parent company's shareholders | 176,845,231.47 | 158,265,044.32 |
2. Non-controlling interests | -4,408,240.69 | -3,249,758.14 |
VI. Net of tax of other comprehensive income | -1,148,916.74 | |
Other net after-tax comprehensive income attributable to the owners of the parent company | -1,195,875.08 | |
(I) Other comprehensive income that cannot be reclassified through profit or loss | ||
1. Changes arising from re-measurement of the defined benefit plan | ||
2. Other comprehensive incomes that cannot be reclassified into profit or loss under the equity method | ||
3. Changes in fair value of other equity instrument investments | ||
4. Changes in fair value of the Company’s credit risk | ||
5. Others | ||
(II) Other comprehensive income to be reclassified into profit or loss | -1,195,875.08 | |
1. Other comprehensive income that can be reclassified into profit or loss under the equity method | ||
2. Changes in fair value of other creditor's rights investments | ||
3. Amount of financial assets reclassified into other comprehensive incomes | ||
4. Provision for impairment of credit in other debt investments | ||
5. Reserves for cash flow hedge | ||
6. Translation difference arising from foreign currency financial statements | -1,195,875.08 | |
7. Others | ||
Other net after-tax comprehensive income attributable to minority shareholders | 46,958.34 | |
VII. Total comprehensive income | 171,288,074.04 | 155,015,286.18 |
Total comprehensive income attributable to the owners of the parent company | 175,649,356.39 | 158,265,044.32 |
Total comprehensive income attributable to minority shareholders | -4,361,282.35 | -3,249,758.14 |
VIII. Earnings per share | ||
(I) Basic earnings per share | 0.42 | 0.37 |
(II) Diluted earnings per share | 0.42 | 0.37 |
In case of business combinations under common control in current period, the net profit realized by the combined party beforecombination is CNY 0.00 and the net profit realized by the combined party in previous period is CNY 0.00.
Legal representative: Guo Zhenyu
CFO: Wang Long
Head ofAccountingDepartment: LiuZhaofeng
3. Consolidated Cash Flow Statement
Unit: CNY
Item | Amount of the Reporting Period | Amount of Precious Reporting Period |
I. Cash flows from operating activities: | ||
Cash received from sales of goods or rendering of services | 1,275,917,110.75 | 944,703,091.31 |
Net increase in deposits from customers and placements from banks and other financial institutions | ||
Net increase in borrowings from the central bank | ||
Net increase in placements from other financial institutions | ||
Cash received for receiving premium of original insurance contract | ||
Net cash received from reinsurance business | ||
Net increase in deposits of the insured and investment | ||
Cash received from interest, handling charges and commission | ||
Net increase in placements from banks and other financial institutions | ||
Net increase in capital for repurchase | ||
Net cash received from securities trading agency services | ||
Taxes and surcharges refunds | 1,585,654.76 | |
Other cash received relating to operating activities | 13,183,620.96 | 10,222,421.43 |
Subtotal of cash inflows from operating activities | 1,289,100,731.71 | 956,511,167.50 |
Cash paid for goods and services | 379,949,715.47 | 336,605,023.22 |
Net increase in loans and advances to customers | ||
Net increase in deposits in the central bank and other financial institutions | ||
Cash paid for claim settlements on original insurance contract | ||
Net increase in placements from banks and other financial institutions | ||
Cash paid for interest, handling charges and commission | ||
Cash paid for policy dividends | ||
Cash paid to and for employees | 235,214,505.18 | 202,534,843.45 |
Payments of taxes and surcharges | 127,754,843.63 | 116,290,752.97 |
Other cash paid relating to operating activities | 703,895,937.42 | 497,851,145.49 |
Subtotal of cash outflows from operating activities | 1,446,815,001.70 | 1,153,281,765.13 |
Net cash flow from operating activities | -157,714,269.99 | -196,770,597.63 |
II. Cash flows from investing activities: | ||
Cash received from the return of investment | 670,000,000.00 | 1,049,617,111.10 |
Cash received from investment incomes | 11,304,135.99 | 10,059,178.94 |
Net cash received from the disposal of fixed assets, intangible assets, and other long-term assets | 2,709,800.00 |
Net cash received from the disposal of subsidiaries and other business entities | ||
Other cash received relating to investing activities | ||
Subtotal of cash inflows from investing activities | 681,304,135.99 | 1,062,386,090.04 |
Cash paid to acquire fixed assets, intangible assets and other long- term assets | 70,935,766.79 | 37,406,207.05 |
Cash paid to acquired investments | 1,041,500,000.00 | 1,641,416,055.23 |
Net increase in pledge loans | ||
Net cash paid for acquisition of subsidiaries and other business entities | 1,002,104.59 | |
Other cash paid relating to investment activities | ||
Subtotal of cash outflows from investing activities | 1,112,435,766.79 | 1,679,824,366.87 |
Net cash flows from investing activities | -431,131,630.80 | -617,438,276.83 |
III. Cash flows from financing activities: | ||
Cash received from absorbing investments | ||
Including: Cash received by subsidiaries from minority shareholders'investments | ||
Cash received from borrowings | 69,222,593.55 | |
Cash received relating to other financing activities | ||
Subtotal of cash inflows from financing activities | 69,222,593.55 | |
Cash paid for repayment of debts | 107,642,857.15 | |
Cash paid for distribution of dividends, profits or interest repayment | 2,491,963.96 | 1,520,824.84 |
Including: cash payments for dividends or profit to minority shareholders of subsidiaries | 1,217,455.37 | 1,520,824.84 |
Other cash paid relating to financing activities | 115,747,177.98 | 20,088,180.36 |
Subtotal of cash outflows from financing activities | 225,881,999.09 | 21,609,005.20 |
Net cash flows from financing activities | -156,659,405.54 | -21,609,005.20 |
IV. Effects from the change of exchange rate on cash and cash equivalents | -942,902.91 | -394.71 |
V. Net increase in cash and cash equivalents | -746,448,209.24 | -835,818,274.37 |
Add: Opening balance of cash and cash equivalents | 2,073,881,743.78 | 2,440,692,701.42 |
VI. Closing balance of cash and cash equivalents | 1,327,433,534.54 | 1,604,874,427.05 |
Legal representative: Guo Zhenyu
CFO: Wang Long
Head of Accounting Department: LiuZhaofeng
(II) Information about Adjusting Related Items in Financial Statements for the Year atthe Beginning of the Year According to New Accounting Standards Since 2024
?Applicable ?N/AFor details, please refer to the Announcement by Yunnan Botanee Bio-Technology Group Co., Ltd. on Changes in AccountingPolicies on cninfo’s website (http://www.cninfo.com.cn)
(iii) Audit Report
Whether the Q1 report has been audited
□Yes ?No
The Q1 report of the Company has not been audited
Board of Directors of Yunnan Botanee Bio-Technology Group Co., Ltd.
April 24, 2024